KR101836918B1 - Feed Composition for Mealworm, Breeding Method for Mealworm Using the Same, And Food Composition Obtained Therefrom - Google Patents
Feed Composition for Mealworm, Breeding Method for Mealworm Using the Same, And Food Composition Obtained Therefrom Download PDFInfo
- Publication number
- KR101836918B1 KR101836918B1 KR1020170111870A KR20170111870A KR101836918B1 KR 101836918 B1 KR101836918 B1 KR 101836918B1 KR 1020170111870 A KR1020170111870 A KR 1020170111870A KR 20170111870 A KR20170111870 A KR 20170111870A KR 101836918 B1 KR101836918 B1 KR 101836918B1
- Authority
- KR
- South Korea
- Prior art keywords
- gaba
- wheat
- acid
- worm
- feed
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 67
- 235000013305 food Nutrition 0.000 title claims abstract description 35
- 238000009395 breeding Methods 0.000 title claims abstract description 20
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 128
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 64
- 238000000034 method Methods 0.000 claims abstract description 19
- 230000001488 breeding effect Effects 0.000 claims abstract description 11
- 230000012010 growth Effects 0.000 claims abstract description 9
- 239000004480 active ingredient Substances 0.000 claims abstract description 5
- 241000209140 Triticum Species 0.000 claims description 89
- 235000021307 Triticum Nutrition 0.000 claims description 89
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 63
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 claims description 29
- 235000013923 monosodium glutamate Nutrition 0.000 claims description 29
- 239000003674 animal food additive Substances 0.000 claims description 7
- 239000004223 monosodium glutamate Substances 0.000 claims description 4
- 230000002708 enhancing effect Effects 0.000 claims description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract description 19
- 235000013922 glutamic acid Nutrition 0.000 abstract description 19
- 239000004220 glutamic acid Substances 0.000 abstract description 19
- 235000020776 essential amino acid Nutrition 0.000 abstract description 6
- 239000003797 essential amino acid Substances 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 description 38
- 239000000284 extract Substances 0.000 description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 20
- 230000000694 effects Effects 0.000 description 20
- 241000238631 Hexapoda Species 0.000 description 14
- 238000000605 extraction Methods 0.000 description 14
- 239000006228 supernatant Substances 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 230000001965 increasing effect Effects 0.000 description 13
- 210000000287 oocyte Anatomy 0.000 description 13
- 239000000523 sample Substances 0.000 description 13
- 108010005551 GABA Receptors Proteins 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- 230000009471 action Effects 0.000 description 11
- 239000000872 buffer Substances 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 11
- 102000005915 GABA Receptors Human genes 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 7
- 229940024606 amino acid Drugs 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 239000006227 byproduct Substances 0.000 description 7
- 230000014509 gene expression Effects 0.000 description 7
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- 230000001419 dependent effect Effects 0.000 description 6
- QKFJKGMPGYROCL-UHFFFAOYSA-N phenyl isothiocyanate Chemical compound S=C=NC1=CC=CC=C1 QKFJKGMPGYROCL-UHFFFAOYSA-N 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 230000037406 food intake Effects 0.000 description 5
- 235000013376 functional food Nutrition 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000004809 thin layer chromatography Methods 0.000 description 5
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 5
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 5
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 4
- 235000003704 aspartic acid Nutrition 0.000 description 4
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- 206010012289 Dementia Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000269370 Xenopus <genus> Species 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 229940117953 phenylisothiocyanate Drugs 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 235000015099 wheat brans Nutrition 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- OYIFNHCXNCRBQI-UHFFFAOYSA-N 2-aminoadipic acid Chemical compound OC(=O)C(N)CCCC(O)=O OYIFNHCXNCRBQI-UHFFFAOYSA-N 0.000 description 2
- QCHPKSFMDHPSNR-UHFFFAOYSA-N 3-aminoisobutyric acid Chemical compound NCC(C)C(O)=O QCHPKSFMDHPSNR-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 241000272525 Anas platyrhynchos Species 0.000 description 2
- 241000272517 Anseriformes Species 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000008214 Glutamate decarboxylase Human genes 0.000 description 2
- 108091022930 Glutamate decarboxylase Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- JDHILDINMRGULE-LURJTMIESA-N N(pros)-methyl-L-histidine Chemical compound CN1C=NC=C1C[C@H](N)C(O)=O JDHILDINMRGULE-LURJTMIESA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 230000002292 Radical scavenging effect Effects 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 241000254107 Tenebrionidae Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 235000019784 crude fat Nutrition 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 239000005417 food ingredient Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- 230000012447 hatching Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- CKDDRHZIAZRDBW-UHFFFAOYSA-N henicosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCC(O)=O CKDDRHZIAZRDBW-UHFFFAOYSA-N 0.000 description 2
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 235000005772 leucine Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-AVQMFFATSA-N linoelaidic acid Polymers CCCCC\C=C\C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-AVQMFFATSA-N 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 235000013930 proline Nutrition 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 230000000384 rearing effect Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 235000021003 saturated fats Nutrition 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 235000010692 trans-unsaturated fatty acids Nutrition 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- XEZVDURJDFGERA-UHFFFAOYSA-N tricosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCC(O)=O XEZVDURJDFGERA-UHFFFAOYSA-N 0.000 description 2
- SZHOJFHSIKHZHA-UHFFFAOYSA-N tridecanoic acid Chemical compound CCCCCCCCCCCCC(O)=O SZHOJFHSIKHZHA-UHFFFAOYSA-N 0.000 description 2
- 235000002374 tyrosine Nutrition 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- GDTXICBNEOEPAZ-FPLPWBNLSA-N (10Z)-heptadecenoic acid Chemical compound CCCCCC\C=C/CCCCCCCCC(O)=O GDTXICBNEOEPAZ-FPLPWBNLSA-N 0.000 description 1
- XSXIVVZCUAHUJO-HZJYTTRNSA-N (11Z,14Z)-icosadienoic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCCC(O)=O XSXIVVZCUAHUJO-HZJYTTRNSA-N 0.000 description 1
- HVGRZDASOHMCSK-HZJYTTRNSA-N (13Z,16Z)-docosadienoic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCCCCC(O)=O HVGRZDASOHMCSK-HZJYTTRNSA-N 0.000 description 1
- GWHCXVQVJPWHRF-KTKRTIGZSA-N (15Z)-tetracosenoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-KTKRTIGZSA-N 0.000 description 1
- QVSVMNXRLWSNGS-UHFFFAOYSA-N (3-fluorophenyl)methanamine Chemical compound NCC1=CC=CC(F)=C1 QVSVMNXRLWSNGS-UHFFFAOYSA-N 0.000 description 1
- LUTLAXLNPLZCOF-UHFFFAOYSA-N 1-Methylhistidine Natural products OC(=O)C(N)(C)CC1=NC=CN1 LUTLAXLNPLZCOF-UHFFFAOYSA-N 0.000 description 1
- QWCKQJZIFLGMSD-UHFFFAOYSA-N 2-Aminobutanoic acid Natural products CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 description 1
- WXHLLJAMBQLULT-UHFFFAOYSA-N 2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-n-(2-methyl-6-sulfanylphenyl)-1,3-thiazole-5-carboxamide;hydrate Chemical compound O.C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1S WXHLLJAMBQLULT-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- BRMWTNUJHUMWMS-UHFFFAOYSA-N 3-Methylhistidine Natural products CN1C=NC(CC(N)C(O)=O)=C1 BRMWTNUJHUMWMS-UHFFFAOYSA-N 0.000 description 1
- MGGVALXERJRIRO-UHFFFAOYSA-N 4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-2-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-1H-pyrazol-5-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)O MGGVALXERJRIRO-UHFFFAOYSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- 108010085443 Anserine Proteins 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 235000003276 Apios tuberosa Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000010744 Arachis villosulicarpa Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 1
- 108010087806 Carnosine Proteins 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- QWCKQJZIFLGMSD-GSVOUGTGSA-N D-alpha-aminobutyric acid Chemical compound CC[C@@H](N)C(O)=O QWCKQJZIFLGMSD-GSVOUGTGSA-N 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000289659 Erinaceidae Species 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- XSXIVVZCUAHUJO-UHFFFAOYSA-N Homo-gamma-linoleic acid Natural products CCCCCC=CCC=CCCCCCCCCCC(O)=O XSXIVVZCUAHUJO-UHFFFAOYSA-N 0.000 description 1
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 238000007696 Kjeldahl method Methods 0.000 description 1
- SLRNWACWRVGMKD-UHFFFAOYSA-N L-anserine Natural products CN1C=NC(CC(NC(=O)CCN)C(O)=O)=C1 SLRNWACWRVGMKD-UHFFFAOYSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- 235000021353 Lignoceric acid Nutrition 0.000 description 1
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 208000017657 Menopausal disease Diseases 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N N,N-Diethylethanamine Substances CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 1
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- XJXROGWVRIJYMO-SJDLZYGOSA-N Nervonic acid Natural products O=C(O)[C@@H](/C=C/CCCCCCCC)CCCCCCCCCCCC XJXROGWVRIJYMO-SJDLZYGOSA-N 0.000 description 1
- SUHOOTKUPISOBE-UHFFFAOYSA-N O-phosphoethanolamine Chemical compound NCCOP(O)(O)=O SUHOOTKUPISOBE-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 101150072055 PAL1 gene Proteins 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 241001668545 Pascopyrum Species 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 229920005372 Plexiglas® Polymers 0.000 description 1
- 241000210053 Potentilla elegans Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241000254109 Tenebrio molitor Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- MHLMRBVCMNDOCW-UHFFFAOYSA-N acetic acid;butan-1-ol;hydrate Chemical compound O.CC(O)=O.CCCCO MHLMRBVCMNDOCW-UHFFFAOYSA-N 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000012445 acidic reagent Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical class O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 1
- MYYIAHXIVFADCU-QMMMGPOBSA-N anserine Chemical compound CN1C=NC=C1C[C@H](NC(=O)CC[NH3+])C([O-])=O MYYIAHXIVFADCU-QMMMGPOBSA-N 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 239000001522 artemisia absinthium l. herb extract Substances 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 150000004652 butanoic acids Chemical class 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- APXSAEQXOXTDAM-WAYWQWQTSA-N cis-10-pentadecenoic acid Chemical compound CCCC\C=C/CCCCCCCCC(O)=O APXSAEQXOXTDAM-WAYWQWQTSA-N 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- GWHCXVQVJPWHRF-UHFFFAOYSA-N cis-tetracosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-UHFFFAOYSA-N 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 235000021316 daily nutritional intake Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
- VLBUZOGLEBQDHB-UHFFFAOYSA-N ethanol;triethylazanium;hydroxide Chemical compound O.CCO.CCN(CC)CC VLBUZOGLEBQDHB-UHFFFAOYSA-N 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- FARYTWBWLZAXNK-WAYWQWQTSA-N ethyl (z)-3-(methylamino)but-2-enoate Chemical compound CCOC(=O)\C=C(\C)NC FARYTWBWLZAXNK-WAYWQWQTSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003031 feeding effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 230000006266 hibernation Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 230000001418 larval effect Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- ZMKDEQUXYDZSNN-UHFFFAOYSA-N linolelaidic acid Natural products CCCCCCCCC=CCC=CCCCCC(O)=O ZMKDEQUXYDZSNN-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000006993 memory improvement Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- JBXYCUKPDAAYAS-UHFFFAOYSA-N methanol;trifluoroborane Chemical compound OC.FB(F)F JBXYCUKPDAAYAS-UHFFFAOYSA-N 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- YWWVWXASSLXJHU-WAYWQWQTSA-N myristoleic acid Chemical class CCCC\C=C/CCCCCCCC(O)=O YWWVWXASSLXJHU-WAYWQWQTSA-N 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000021075 protein intake Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- -1 ring Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 235000014393 valine Nutrition 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229940119569 wormwood extract Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/90—Feeding-stuffs specially adapted for particular animals for insects, e.g. bees or silkworms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L35/00—Food or foodstuffs not provided for in groups A23L5/00 – A23L33/00; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/70—Invertebrates
- A01K2227/706—Insects, e.g. Drosophila melanogaster, medfly
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/038—Gamma-amino butyric acid
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Biotechnology (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Insects & Arthropods (AREA)
- Birds (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
본 발명은 밀웜용 사료 조성물, 이를 이용한 사육방법 및 이로부터 얻은 곤충 식품 조성물에 관한 것으로, 상세하게는 글루탐산을 유효성분으로 함유하는 밀웜용 사료 조성물, 이를 이용하여 밀웜을 사육하는 방법 및 그 사육방법으로 사육되어 가바(GABA; gamma aminobutyric acid) 함량이 증진된 밀웜을 함유하는 식품 조성물에 관한 것이다.The present invention relates to a feed composition for wheat worms, a feeding method using the same and an insect food composition obtained therefrom, and more particularly to a feed composition for wheat worms containing glutamic acid as an active ingredient, a method for breeding wheat worms using the composition, (Gamma aminobutyric acid) content of the wheat worm.
최근 곤충자원의 탐색, 보전을 통한 생물자원 확보경쟁이 날로 치열해지고 있는 가운데 이들의 가치평가 및 이용개발 연구가 매우 활발히 수행되고 있다. 이러한 연구의 일환으로 국내외적으로 곤충으로부터 식·의약소재개발에 대한 연구도 진행되고 있다. In recent years, competition for securing biological resources through exploration and conservation of insect resources has become fierce, and their valuation and utilization research are being actively carried out. As part of this research, research on the development of food and medicine materials from insects has also been carried out domestically.
거저리과(Tenebrionidae)는 딱정벌레목에 포함되는 곤충으로서, 따뜻하고 건조한 기후에서 흔하게 볼 수 있으며, 대부분 건조하고 부패된 식물이나 동물조직을 먹으며 살아간다. 이러한 거저리과(Tenebrionidae)의 유충은 길이가 약 25mm에 원통형으로 벌레모양을 하고 있으며, 흔히 밀웜(Mealworm)이라고도 불리우는데, 그 기간은 약 15~20주이나, 변태기간이 비교적 짧아 성장이 빠르며, 번식률도 매우 높으며, 곡식을 먹이로 하는 청결한 곤충이다.Tenebrionidae are insects in the beetle's neck that are common in warm, dry climates and live on mostly dry, decayed plants or animal tissues. The larvae of this species, Tenebrionidae, are about 25mm in length and cylindrical in shape, and are often called Mealworm, which is about 15 to 20 weeks old. The larval stage is relatively short, Is also very high and is a clean insect that feeds on grain.
거저리과 유충의 대부분은 애완용 새나 물고기 또는 고슴도치 등의 먹이로 쓰이며, 그 중에서도 갈색거저리(Tenebrio molitor, mealworm, TM) 유충이 가장 많이 이용된다. 갈색거저리는 갈색쌀거저리 또는 고소애 라고도 불리며 한국을 비롯한 전 세계에 분포한다. 갈색거저리는 풍부한 지방, 단백질, 다양한 종류의 아미노산, 불포화지방산, 미네랄을 함유하고 있으며, 필수 아미노산 함량은 돼지고기, 양고기, 콩보다 높고, 쇠고기, 생선과 비슷한 것으로 보고되었다. Most of the larvae and larvae are used as food for pet birds, fish or hedgehogs. Among them, brown larvae (Tenebrio molitor, mealworm, TM) larvae are most commonly used. Brown ducks are also called brown rice gruel or soporaceae and are distributed all over the world including Korea. The brown duck contains abundant fat, protein, various kinds of amino acids, unsaturated fatty acids and minerals. Essential amino acid content is higher than pork, lamb and beans, and it is reported to be similar to beef and fish.
갈색거저리는 알, 유충, 번데기 및 성충의 시기를 거치는 완전변태를 하는 곤충이지만 다른 곤충들과 달리 변태기간이 비교적 짧고 적응력이 강하며 사육기술을 익히기 쉬워 연중 사육이 가능하다. 이러한 짧은 생활사와 강한 생존율 때문에 낮은 사료비로 사육이 가능하며, 사육시 평소에 거의 사용되지 않는 밀짚과 오래된 배추 잎을 먹이원으로 쓸수 있어 친환경적이다.Brown ducks are fully transformed insects that pass through eggs, larvae, pupae, and adults. However, unlike other insects, they are relatively short in transformation period, adaptable, and easy to learn breeding techniques. Because of this short life cycle and strong survival rate, it is possible to breed with low feed costs, and it is eco-friendly because it can be used as a food source of straw and old cabbage leaves which are rarely used at the time of breeding.
밀웜은 손쉽게 대량증식이 가능하고 영양적인 가치가 높아 사료용, 식용 등 산업적 용도 개발에 대한 관심이 점차 증대되는 추세이다. 단백질 함량이 매우 높아 네덜란드와 멕시코를 비롯한 남미, 유럽, 중국 등 국외에서는 식용으로 널리 사용되고 있다. 국내에서는 10여년 전부터 애완동물의 사료로서 많이 활용되었고, 곤충애호가들이나 동물원 등에서 사육하기 시작하면서 최근 사료용 곤충으로서 여러가지 장점이 부각되고 있다. 또한, 2016년 식약청에 밀웜이 정식으로 일반식품원료로 등재되어, 상업화를 목적으로 대량 증식하는 농가가 생겨나고 있다. The wheyworm is easy to mass-proliferate and has high nutritional value, so that there is a growing interest in the development of industrial applications such as feed and edible. Because of its high protein content, it is widely used for food in the Netherlands, Mexico, South America, Europe and China. Domestic animals have been widely used as feed for pet animals for more than 10 years and have begun breeding in insect lovers and zoos. In addition, in 2016, the KIRM has been officially registered as a general food ingredient in the KFDA, and farmers are growing in quantity for commercialization.
가바(γ-amino-n-butyric acid, GABA)는 4개의 탄소로 구성되어 있는 비단백질 구성 아미노산의 억제성 신경 전달 물질이다. 사람에게는 대부분 뇌의 골수에 존재하며 신경전달물질인 아세틸콜린(acetylcholine)을 증가시키고, 뇌기능을 촉진시키는 등의 생리작용을 한다. 가바의 알려진 효능으로는 중풍 및 치매 예방, 집중력 강화, 기억력 증진, 불면 및 우울증의 해소 등이 있다. 또한, 신경 안정 작용, 숙취해소, 불안감 해소, 혈압 강하, 인슐린 효과 증대도 보고되어 있다. 최근에는 항암 효과를 가진 것이 밝혀져 식품업계에서 주목을 받고 있으며, 해외에서는 가바의 섭취를 위한 보충제가 출시되어 시판되고 있는 실정이다.Γ-amino-n-butyric acid (GABA) is an inhibitory neurotransmitter of non-protein constituent amino acids composed of four carbons. In most people, it exists in the bone marrow of the brain, increases the neurotransmitter acetylcholine, and physiologically acts to promote brain function. Known effects of Gabba include prevention of stroke and dementia, strengthening concentration, improving memory, relieving insomnia and depression. In addition, neurostabilizing action, relieving hangover, relieving anxiety, lowering blood pressure, and increasing insulin effect have also been reported. In recent years, it has been shown that it has anticancer effect and it is attracting attention in the food industry. In abroad, supplements for the intake of GABA are available and marketed.
본 발명은 밀웜의 생육속도를 향상시키고 체내 가바 함량을 증진시킬 수 있는 밀웜용 사료 조성물을 제공하는 것을 목적으로 한다.It is an object of the present invention to provide a feed composition for wheat worm which can improve the growth speed of the wheat worm and increase the body grain content.
본 발명은 상기 밀웜용 사료 조성물을 밀웜에게 급여하는 단계를 포함하는 밀웜의 사육방법을 제공하는 것을 목적으로 한다.The present invention aims at providing a feeding method for a wheat worm comprising feeding the wheat worm feed composition to the wheat worm.
본 발명은 상기 밀웜의 사육방법에 따라 사육되어 가바 함량이 증진된 밀웜을 제공하는 것을 다른 목적으로 한다.It is another object of the present invention to provide a wheat worm which is raised according to the method for raising the wheat worm, thereby increasing the amount of garbage.
본 발명은 상기 가바 함량이 증진된 밀웜 또는 이의 추출물을 포함하는 식품 조성물을 제공하는 것을 다른 목적으로 한다.It is another object of the present invention to provide a food composition comprising the wheat worm or the extract thereof, wherein the gastric content is enhanced.
본 발명의 일 측면에 따르면, 글루탐산을 유효성분으로 포함하는 생육증진 및 가바(GABA; gamma aminobutyric acid) 합성 증진용 밀웜 사료 조성물이 제공된다.According to one aspect of the present invention, there is provided a wheat worm feed composition for promoting growth and gamma aminobutyric acid (GABA) synthesis comprising glutamic acid as an active ingredient.
또한, 상기 글루탐산은 모노소듐 글루타메이트(Mono sodium glutamate)일 수 있다.In addition, the glutamic acid may be monosodium glutamate.
또한, 상기 글루탐산은 상기 사료 조성물 100중량%를 기준으로 5 내지 50중량%의 함량으로 포함될 수 있다.The glutamic acid may be contained in an amount of 5 to 50% by weight based on 100% by weight of the feed composition.
본 발명의 다른 측면에 따르면, 상기 사료 조성물을 밀웜에게 급여하는 단계를 포함하는 것을 특징으로 하는 밀웜 사육방법이 제공된다.According to another aspect of the present invention, there is provided a method of raising a wheat worm, comprising feeding the feed composition to a wheat worm.
본 발명의 다른 측면에 따르면, 상기 사육방법으로 사육되어 가바 함량이 증진된 것을 특징으로 하는 밀웜이 제공된다.According to another aspect of the present invention, there is provided a wheat worm which is raised by the above-mentioned breeding method and has an increased amount of GABA.
본 발명의 다른 측면에 따르면, 상기 밀웜 또는 그 추출물을 함유하는 식품 조성물이 제공된다.According to another aspect of the present invention, there is provided a food composition containing the wheat worm or an extract thereof.
본 발명의 다른 측면에 따르면, 상기 밀웜 또는 그 추출물을 함유하는 사료 첨가제가 제공된다.According to another aspect of the present invention, there is provided a feed additive containing the wheat worm or an extract thereof.
본 발명의 일 측면에 따른 밀웜용 사료 조성물은 그를 섭취하는 밀웜의 생육속도를 향상시켜 생육시간을 단축시킬 수 있다. 이를 통하여, 밀웜을 이용한 사료 또는 식품 조성물의 제조를 위한 밀웜 사육 농가 생산성을 향상시킬 수 있다.The feed composition for a wheat worm according to one aspect of the present invention can shorten the growth time by improving the growth speed of the wheat worm that ingests it. This makes it possible to improve the productivity of the wheat worm farm for the production of feed or food composition using the wheat worm.
또한, 상기 사료 조성물을 밀웜에게 급여함으로써 밀웜의 체내 가바 함량을 현저하게 증진시킬 수 있다. 이를 통하여, 체내 가바 함량이 현저하게 증진된 밀웜을 생산할 수 있다.In addition, by feeding the feed composition to the wheat worm, it is possible to remarkably increase the body burden of the wheat worm. Through this, it is possible to produce wheat worms with significantly increased body fat content.
또한, 가바 함량 증진된 밀웜 또는 그 추출물을 이용하여 가바를 고함량으로 포함하는 기능성 식품 조성물을 제조할 수 있다. In addition, a functional food composition containing a high content of GABA can be prepared using the wheat worm or the extract thereof, which has increased the GABA content.
도 1은 본 발명의 사료 조성물을 급여한 밀웜의 활동성 및 생육속도가 우수한 것을 보여주는 도이고,
도 2는 본 발명의 사료 조성물을 급여한 밀웜 에탄올 추출물의 TLC 분석결과를 나타낸 도이고,
도 3은 본 발명의 사료 조성물을 급여한 밀웜 물 추출물의 TLC 분석결과를 나타낸 도이고,
도 4는 GABA 농도별 HPLC 크로마토그램을 나타낸 도이고,
도 5는 본 발명의 사료 조성물을 급여한 밀웜 물 추출물의 HPLC 크로마토그램을 나타낸 도이고,
도 6은 GABA cRNA를 주입한 세포의 유전자 발현을 확인한 도이고,
도 7은 GABA cRNA를 주입한 세포에 GABA 단일 성분의 농도 구배 실험을 수행한 결과를 나타낸 도이고,
도 8은 GABA cRNA를 주입한 세포에 본 발명의 사료 조성물을 급여한 밀웜 추출물의 농도 구배 실험을 수행한 결과를 나타낸 도이고,
도 9는 GABA cRNA를 주입한 세포에 본 발명의 사료 조성물을 급여한 밀웜 추출물의 농도 구배 실험 결과 커브를 나타낸 도이고,
도 10은 GABA cRNA를 주입한 세포에 본 발명의 사료 조성물을 급여한 밀웜 추출물의 전압의존성 실험 결과를 나타낸 도이다.FIG. 1 is a graph showing an activity and growth rate of a wheat worm fed with the feed composition of the present invention,
FIG. 2 is a graph showing the results of TLC analysis of the wheat-worm ethanol extract fed with the feed composition of the present invention,
FIG. 3 is a graph showing the results of TLC analysis of the wheat worm water extract fed with the feed composition of the present invention,
FIG. 4 is an HPLC chromatogram showing the concentration of GABA,
FIG. 5 is a graph showing HPLC chromatogram of a watery extract of wheat worm fed with the feed composition of the present invention.
FIG. 6 is a graph showing gene expression of cells injected with GABA cRNA,
FIG. 7 is a graph showing the concentration gradient experiment of GABA single component in cells injected with GABA cRNA,
FIG. 8 is a graph showing the results of concentration gradient experiments of wheat worm extracts fed with the feed composition of the present invention to cells injected with GABA cRNA.
FIG. 9 is a graph showing a concentration gradient experiment curve of a wheat worm extract fed with a feed composition of the present invention to cells injected with GABA cRNA,
FIG. 10 is a graph showing the results of voltage-dependency of the extract of the wheat worm obtained by feeding the feed composition of the present invention to cells injected with GABA cRNA.
본 발명은 글루탐산을 포함하는 밀웜 사료 조성물, 이를 이용한 사육방법, 그 사육방법으로 사육되어 가바 함량이 증진된 밀웜 및 이를 함유하는 식품 조성물에 관한 것이다.The present invention relates to a wheat worm feed composition containing glutamic acid, a breeding method using the same, a wheat worm raised by the breeding method, and a food composition containing the wheat worm.
이하, 본 발명을 보다 상세히 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명의 일 측면에 따르면, 밀웜용 사료 조성물이 제공된다.According to one aspect of the present invention, a feed composition for wheat worms is provided.
본 발명의 밀웜용 사료 조성물은 글루탐산을 포함한다. 상기 글루탐산은 모노소듐 글루타메이트(Mono sodium glutamate, 이하 MSG라 기재함)일 수 있다. 밀웜에게 글루탐산을 포함하는 사료 조성물을 급여하는 경우 밀웜의 생육 및 활동성이 촉진되는 효과가 있다. 또한, 밀웜 체내 가바(GABA; gamma aminobutyric acid) 및 필수 아미노산 함량이 증가되는 효과가 있다. 상기 글루탐산은 상기 사료 조성물 100중량%를 기준으로 5 내지 50중량%의 함량으로 포함될 수 있다. 상기 글루탐산 함량이 5중량% 미만이면 첨가로 인한 효과를 나타내기 어렵고, 50중량%를 초과하는 경우에는 사료 조성물의 제조비용이 상승하여 경제성이 저하되는 문제가 발생할 수 있다. 바람직하게는, 글루탐산의 함량으로 인한 증진효과를 극대화하면서도 사료 조성물의 생산 단가를 저감시키기 위하여 상기 글루탐산은 상기 사료 조성물 100중량%를 기준으로 5 내지 20중량%의 함량으로 포함되는 것이 좋다. 보다 바람직하게는, 10 내지 15중량%의 함량으로 포함되는 것이 좋다.The feed composition for wheat worms of the present invention comprises glutamic acid. The glutamic acid may be monosodium glutamate (hereinafter referred to as MSG). Feeding the feed composition containing glutamic acid to the wheat worm promotes the growth and activity of the wheat worm. In addition, there is an effect of increasing GABA (gamma aminobutyric acid) and essential amino acid content. The glutamic acid may be contained in an amount of 5 to 50% by weight based on 100% by weight of the feed composition. If the content of glutamic acid is less than 5% by weight, it is difficult to exhibit the effect of addition. If the content of glutamic acid is more than 50% by weight, the production cost of the feed composition increases and the economical efficiency may decrease. Preferably, the glutamic acid is contained in an amount of 5 to 20% by weight based on 100% by weight of the feed composition in order to maximize the enhancing effect due to the content of glutamic acid while reducing the production cost of the feed composition. More preferably, it is contained in an amount of 10 to 15% by weight.
상기 사료 조성물은 곡물, 채소 및 농업부산물로 이루어진 군에서 선택되는 적어도 하나를 포함할 수 있다. 상기 곡물, 채소 및 농업부산물은 밀웜이 식이가능한 것이라면 특별히 제한되지는 않으며, 통상적으로 사료 제조시 첨가되는 것이 사용될 수 있다. 사료 조성물의 생산단가를 낮추고 경제성을 증진시키기 위하여, 상기 사료 조성물은 농업부산물을 포함하는 것이 바람직하다. 본 발명의 사료 조성물이 상기 농업부산물을 포함하는 경우 사료 제조비용을 저감시켜 생산성을 증대시킬 수 있다. 또한, 농업부산물을 재활용함으로써 자연적 선순환이 발생하게 되므로 환경친화적 효과를 나타낼 수 있다. 상기 농업부산물은 농업 생산에서 부차적으로 얻는 생산물로, 예를 들면 미강, 밀기울, 면실피, 면실박, 옥공이, 낙화생피 및 비트펄프로 이루어진 군에서 선택되는 적어도 하나를 사용할 수 있다. 밀웜의 섭식기호를 고려하는 경우, 밀기울이 선택되는 것이 보다 바람직하다. 상기 곡물, 채소 및 농업부산물은 상기 사료 조성물 100중량%를 기준으로 50 내지 95중량%의 함량으로 포함될 수 있다.The feed composition may comprise at least one selected from the group consisting of cereals, vegetables and agricultural by-products. The cereals, vegetables, and agricultural by-products are not particularly limited as long as they are capable of eating wheat worms, and those normally added during the production of feed can be used. In order to lower the production cost of the feed composition and improve the economic efficiency, it is preferable that the feed composition includes agricultural by-products. When the feed composition of the present invention includes the agricultural by-products, the feed production cost can be reduced and the productivity can be increased. In addition, recycling of agricultural byproducts results in a natural circulation, which can be environmentally friendly. The agricultural by-products are products obtained by secondary production in agricultural production, for example, at least one selected from the group consisting of rice bran, wheat bran, cotton bran, cotton bran, jade bran, groundnut bran and beet pulp. In consideration of the eating symbol of the wheat worm, it is more preferable that wheat bran is selected. The cereals, vegetables and agricultural by-products may be contained in an amount of 50 to 95% by weight based on 100% by weight of the feed composition.
필요에 따라, 상기 사료 조성물은 사료 첨가제를 더 포함할 수 있다. 상기 첨가제는 기호성 또는 기능성의 증진을 목적으로 당 업계에 공지된 것을 사용할 수 있다. 상세하게는, 밀웜의 상태 개선, 생산성 향상 및 품질 향상에 있어 긍정적인 효과를 얻기 위해 각종 항생제, 생균제, 효소제, 유기산제, 향미제, 감미제, 항산화제 및 기타 기능성 물질로 이루어진 군에서 선택되는 적어도 하나를 더 사용할 수 있다.If desired, the feed composition may further comprise a feed additive. The additives may be those known in the art for the purpose of enhancing taste or functionality. More particularly, the present invention relates to a pharmaceutical composition for improving the condition, productivity and quality of a wheat worm, which comprises at least one selected from the group consisting of various antibiotics, probiotics, enzymes, organic acids, flavors, sweeteners, antioxidants, You can use one more.
본 발명의 다른 측면에 따르면, 상기 사료 조성물을 밀웜에게 급여하는 단계를 포함하는 밀웜 사육방법이 제공된다. According to another aspect of the present invention, there is provided a method of raising a wheat worm, comprising feeding the feed composition to a wheat worm.
본 발명의 밀웜용 사료 조성물을 급여할 수 있는 시기는 특별히 한정되지 않으며, 부화 직후의 유충부터 성충 직전의 유충까지 모두 급여할 수 있다. 바람직하게는, 부화 직후부터 급여하는 것이 좋다. 이 경우, 그를 이용한 식품소재의 공급에 있어 사육기간이 단축되고 밀웜을 다루는 데 필요한 노력이 저감되므로 전체적인 생산성이 증대될 수 있다. 또한, 식품소재로 이용되는 경우 기호성 및 적용 범위가 보다 증진될 수 있다.There is no particular limitation on the time at which the feed composition for wheat worms of the present invention can be fed, and the feed can be fed from larva immediately after hatching to larva immediately before adult. Preferably, it is preferable to feed from immediately after hatching. In this case, the overall productivity can be increased by shortening the rearing period and reducing the effort required to deal with the wheat worm in supplying the food material using the same. In addition, when used as a food material, palatability and application range can be further improved.
본 발명의 밀웜용 사료 조성물을 급여하는 기간은 특별히 한정되지 않으며, 밀웜의 체내 가바 함량을 증진시키기 위하여 1주 내지 4개월, 바람직하게는 2 내지 3개월의 기간동안 급여할 수 있다. The feeding period of the feed composition for wheat worms of the present invention is not particularly limited, and the feed can be fed for a period of one week to four months, preferably two to three months, in order to enhance the body burden of the worm.
상기 사육방법으로 밀웜을 사육함으로써 체내 가바 함량이 증진된 밀웜을 얻을 수 있다.By raising the wheat worm by the breeding method, a wheat worm having an increased body burden can be obtained.
본 발명의 밀웜용 사료 조성물을 급여하여 사육된 밀웜은 체내 가바 함량이 현저히 증진된다. 상기 밀웜의 체내 가바 함량은 본 발명의 사료 조성물의 섭취량, 사료내 글루탐산 함량, 사료 조성물의 급여기간에 따라 달라질 수 있다. 상기 밀웜은 가바 외에도 체내 필수 아미노산 함량이 증진된다. The wheat worm raised by feeding the feed composition for wheat worm according to the present invention significantly improves the body burden. The gastric content in the body of the wheat worm may vary depending on an intake amount of the feed composition of the present invention, an amount of glutamate in the feed, and a feeding period of the feed composition. In addition to GABA, the above-mentioned wheat worm also increases essential amino acid content in the body.
본 발명의 체내 가바 함량이 증진된 밀웜은 그 자체로도 식품으로 이용 가능하며, 분말, 캡슐, 환, 추출물 등 다양한 형태로 제조하여 이용할 수도 있다.The wheat worm having increased body burden of the present invention can be used as food itself, and can be prepared in various forms such as powder, capsule, ring, and extract.
필요에 따라, 본 발명의 밀웜은 그를 추출하여 얻은 추출물의 형태로 사용될 수 있다. 상기 밀웜 추출물의 분리방법은 특별히 한정되지는 않으나, 추출물을 제조하기 위해 당업계에서 통상적으로 이용하는 방법을 이용할 수 있다. 예를 들면, 열수 추출, 침지 추출, 환류 냉각 추출, 초임계추출, 아임계추출, 고온추출, 고압추출, 초음파추출 등의 추출장치를 이용하는 방법 또는 XAD 및 HP-20을 포함하는 흡착 수지를 이용하는 방법 등을 사용할 수 있으나 이에 한정되는 것은 아니다. 바람직하게는, 추출 용매를 처리하여 열수 추출한 후 감압 농축하여 수득할 수 있다. 상기 추출 용매로는, 예를 들면, 물, 에탄올, 부틸렌글리콜, 프로필렌글리콜, 디프로필렌글리콜 및 글리세린으로 이루어진 군에서 선택되는 적어도 하나가 사용될 수 있다. 바람직하게는, 물이 이용되는 것이 좋다.If necessary, the wheat worm of the present invention can be used in the form of an extract obtained by extracting it. The method for separating the extract of the mildew worm is not particularly limited, but a method commonly used in the art can be used for producing the extract. For example, a method using an extraction device such as hot water extraction, immersion extraction, reflux cooling extraction, supercritical extraction, subcritical extraction, high temperature extraction, high pressure extraction and ultrasonic extraction, or a method using an adsorption resin containing XAD and HP-20 Method, but the present invention is not limited thereto. Preferably, it can be obtained by treating with an extraction solvent, extracting it with hot water, and concentrating it under reduced pressure. As the extraction solvent, for example, at least one selected from the group consisting of water, ethanol, butylene glycol, propylene glycol, dipropylene glycol and glycerin can be used. Preferably, water is used.
본 발명의 밀웜 또는 그 추출물은 증진된 함량의 가바를 포함하므로, 가바 섭취 또는 보충을 위한 식용 소재로 유용하게 사용될 수 있다. 또한, 본 발명의 밀웜 또는 그 추출물은 생산공정이 간편 용이하고 대량생산이 가능하므로 저렴한 가격으로 고품질의 고 가바함유 식용 소재를 제조할 수 있다.The wheat worm or its extract of the present invention contains a promoted content of GABA, so that it can be usefully used as an edible material for GABA ingestion or replenishment. In addition, the wheat worm or the extract thereof of the present invention can be easily produced and mass-produced, so that high-quality edible materials containing high-quality can be produced at low cost.
본 발명의 밀웜 또는 그 추출물은 식품 조성물로 제조될 수 있다. 상기 식품 조성물의 종류로는, 예를 들면, 드링크제, 육류, 소세지, 빵, 비스켓, 떡, 초콜릿, 캔디, 스낵, 과자, 피자, 면류, 껌, 아이스크림, 스프, 음료, 차, 비타민 복합제 등이 있으나 이에 한정되는 것은 아니다. 또한, 통상적인 의미의 기능성 식품을 모두 포함한다. 상기 기능성 식품이란 밀웜 추출물을 식품소재에 첨가하여 제조된 식품이거나, 밀웜 추출물을 정제, 캡슐, 분말, 현탁액 등의 제형으로 제조한 식품으로, 이를 섭취할 경우 건강상 특정한 효과를 가져오는 통상적인 의미의 건강 식품을 포함한다. 상기 식품의 형태는 분말, 과립, 정제, 캡슐, 액상 또는 음료 형태일 수 있다. The wheat worm or extract thereof of the present invention can be produced with a food composition. Examples of the food composition include drinks, meats, sausages, bread, biscuits, rice cakes, chocolate, candy, snacks, confectionery, pizza, noodles, gum, ice cream, soups, drinks, tea, But is not limited thereto. In addition, it includes all functional foods in a conventional sense. The functional food refers to a food prepared by adding a wheat-worm extract to a food material, or a food prepared by preparing a wheat-worm extract in tablets, capsules, powders, suspensions or the like, and has a usual meaning Of healthy foods. The form of the food may be in the form of a powder, a granule, a tablet, a capsule, a liquid or a drink.
본 발명의 밀웜 또는 그 추출물은 식품에 그대로 첨가하거나 다른 식품 또는 식품 성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효 성분의 혼합 함량은 그의 사용 목적에 따라 적합하게 결정될 수 있다. 일반적으로, 식품 조성물 내에서 상기 밀웜 또는 그 추출물의 함량은 전체 식품 중량의 0.0001 내지 99.9중량%로 포함될 수 있다. The wheat worm or extract thereof of the present invention can be added directly to the food or can be used together with other food or food ingredients, and can be suitably used according to a conventional method. The mixed content of the active ingredient may be appropriately determined depending on the purpose of use thereof. Generally, the content of the wheat worm or its extract in the food composition may be 0.0001 to 99.9% by weight of the total food weight.
필요에 따라, 본 발명의 식품 조성물은 식품 제조 시에 통상적으로 첨가되는 성분을 더 포함할 수 있다. 예를 들면, 영양제, 비타민, 광물(전해질), 풍미제, 착색제, 중진제, 펙트산, 펙트산염, 알긴산, 알긴산염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산화제, 과육 등을 더 포함할 수 있으나 이에 한정되는 것은 아니다.If desired, the food composition of the present invention may further comprise ingredients that are conventionally added in food preparation. For example, there may be mentioned nutrients, vitamins, minerals (electrolytes), flavors, coloring agents, thickening agents, pectic acid, pectate salts, alginic acid, alginates, organic acids, protective colloid thickening agents, pH adjusting agents, stabilizers, preservatives, , Carbonating agent, pulp, and the like, but is not limited thereto.
본 발명의 식품 조성물의 섭취를 통하여 신경안정 작용, 스트레스 해소, 기억력 증진, 혈압강하 작용, 우울증 완화, 중풍과 치매 예방, 불면, 비만, 갱년기 장애, 당뇨 등의 개선효과를 나타낼 수 있다. 또한, 밀웜은 불포화지방산이 다수 함유되어 있는 고단백 식품으로, 이의 섭취를 통하여 다양한 필수 또는 비필수 아미노산을 섭취할 수 있으므로, 인체의 신진대사 또는 생체기능의 촉진효과를 발휘하여 건강한 신체를 유지할 수 있도록 하는 건강개선 효과가 있다. The ingestion of the food composition of the present invention can exhibit the effects of improving nervous stability, relieving stress, improving memory, lowering blood pressure, relieving depression, preventing stroke and dementia, insomnia, obesity, menopausal disorder and diabetes. In addition, wheat worm is a high-protein food containing a large amount of unsaturated fatty acids. It can take various essential or non-essential amino acids through its ingestion, so that it can maintain the healthy body by exercising the metabolism or promoting function of the human body. There is a health improvement effect.
본 발명의 밀웜 또는 그 추출물은 사료 또는 사료 첨가제로 제조될 수 있다. 상기 사료 첨가제는 가축의 사료에 첨가되는 성분으로서, 가축에 급여함으로써 가축의 생체 내에서 다양한 생리기능을 발휘하도록 특정 목적을 가지고 첨가될 수 있다. 상기 사료 첨가제로는, 예를 들면, 생균제, 효소제, 광물질, 항생제 및 비타민제 등이 있으나 이에 한정되는 것은 아니다. 상기 사료 또는 사료 첨가제는 소, 돼지, 닭 등에 급여하는 축산사료 또는 수산생물에 급여하는 양식사료에 첨가될 수 있다.The wheat worm or its extract of the present invention can be produced as a feed or feed additive. The feed additive is added to the feed of livestock and can be added to the livestock for specific purposes so as to exert various physiological functions in vivo. Examples of the feed additives include, but are not limited to, probiotics, enzymes, minerals, antibiotics, and vitamins. The feed or feed additive may be added to animal feed fed to cattle, pigs, chickens or the like or aquaculture feed fed to aquatic organisms.
이하, 본 발명의 이해를 돕기 위하여 본 발명을 하기 실시예에 의거하여 좀 더 상세하게 설명한다. 단, 이들 실시예는 본 발명을 예시하는 것일 뿐 첨부된 특허청구범위를 제한하는 것이 아니며, 본 발명의 범주 및 기술사상 범위 내에서 실시예에 대한 다양한 변경 및 수정이 가능함은 당업자에게 있어서 명백한 것이며, 이러한 변형 및 수정이 첨부된 특허청구범위에 속하는 것도 당연한 것이다.BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the present invention will be described in more detail with reference to the following examples. It will be apparent to those skilled in the art that these embodiments are illustrative of the present invention and are not intended to limit the scope of the appended claims and that various changes and modifications may be made to the embodiments within the scope and spirit of the invention , And it is natural that such variations and modifications fall within the scope of the appended claims.
실시예Example
<MSG 첨가 사료의 생육 촉진 효과 확인><Confirmation of growth promoting effect of MSG supplemented feed>
하기 표 1의 배합비율로 글루탐산을 포함하는 본 발명의 사료를 제조하였다. 첨가 글루탐산으로 MSG를 사용하였다.Feeds of the present invention containing glutamic acid were prepared at the blending ratios shown in Table 1 below. MSG was used as added glutamic acid.
사육대상인 갈색거저리는 체를 이용하여 성충 및 유충을 거르고 미부화 알만을 4개의 사육상자 안에 준비하였다. 각 사육상자별로 상기 제조된 사료를 투입하였으며, 온도 25 내지 29℃, 습도 50 내지 70%를 유지하면서 60~90일간 사육을 실시하였다. The brown duck, which is a subject of rearing, was sieved using adult sperm and larvae, and only four eggs were prepared in four breeding boxes. The prepared diets were added to each breeding box and breeding was carried out for 60 to 90 days while maintaining the temperature at 25 to 29 캜 and the humidity of 50 to 70%.
그 결과, MSG를 첨가하지 않은 비교예 사료 급여군에 비하여, MSG를 첨가한 실시예들의 사료 급여군에 속하는 밀웜이 보다 우수한 활동성 및 생육속도를 나타냈다. 상기 비교예 및 실시예2의 사료를 급여한 결과를 도 1에 나타냈다. As a result, the wheat worms belonging to the feed group of the MSG supplemented groups exhibited better activity and growth rate, as compared to the comparative feed ward group to which no MSG was added. The results of feeding the diets of the above Comparative Examples and Example 2 are shown in Fig.
<MSG 급여 사육된 밀웜의 영양성분 분석><Nutritional analysis of wheat worms fed MSG diet>
밀웜의 일반성분은 AACC법에 의하여 분석하였다. 시료로는 비교예 사료 급여군의 유충을 이용하였으며, 수분은 상압가열건조법, 단백질은 semi micro-kjeldahl법, 지방 함량은 Soxhlet법, 회분 함량은 550℃에서 6시간 회화하여 평량을 구하여 건식회화법으로 측정하고 그 결과를 하기 표 2에 나타냈다. 표 2에서, 각 성분의 단위는 g/100g이다.The general components of wheat worms were analyzed by the AACC method. As for the samples, the larvae of the feed group of the comparative example were used, and the basis weight was determined by using atmospheric pressure heating drying method, semi micro-kjeldahl method for moisture, Soxhlet method for fat content, and ash content at 550 ° C. for 6 hours. And the results are shown in Table 2 below. In Table 2, the unit of each component is g / 100g.
일반성분 분석 결과, 밀웜의 조지방 함량은 35.38g/100g로 나타났다. 이는 후술할 지방산 측정 결과와 연계하여 생각하면, 밀웜의 불포화지방산 함량이 높은 이유로 조지방 또한 높게 나타난 것으로 판단된다. As a result of the general composition analysis, the crude fat content of the wheat worm was 35.38 g / 100 g. Considering the result of the fatty acid measurement described below, it is considered that crude lipid was also high because of the high unsaturated fatty acid content of the wheat worm.
밀웜의 아미노산 성분은 자동분석기를 이용하여 분석하였다. 상세하게는, 먼저 각 비교예 및 실시예별로 밀웜 시료 2g에 무수 알코올 20㎖를 첨가하여 균질화 한 다음, 원심분리기를 이용 3000rpm에서 30분간 원심분리하고 상층액 (A)을 따로 모아 두고, 침전물에 다시금 75%(v/v) 알코올 10mL을 첨가하여 잘 혼합한 후 균질화 하여 다시금 위와 같은 방법으로 원심분리를 행하여 얻어진 상층액 (B)를 상층액 A와 혼합한 뒤에 진공 농축기(WB-2001, Heidolph, Kelheim, Germany)를 이용하여 상층액 내의 알코올을 제거하였다. 알코올이 농축 제거된 용액에 8 ㎖의 HPLC 용 water를 첨가하고 0.2 g sulfosalicylic acid 시약을 용해시켜주었다. 이 혼합액을 4℃에서 한 시간동안 방치한 뒤, 다시 3000 rpm으로 30분 동안 원심분리를 하고 상층액을 취하여 HPLC용 water로 10㎖가 되도록 정용하고 0.2um membrane filter (Whatman, Maidstone, UK)로 여과하여 분석용 시료 용액을 제조하였다. 유리아미노산의 분석을 위해 아미노산 자동분석기(S430, SYKAM, Eresing, Germany)를 사용하였으며, 사용된 버퍼는 lithium buffer 용액과 ninhydrin 시약을 사용하여 한 시료 당 2시간동안 분석을 진행하여 유리아미노산에 대하여 분석을 진행하였다. 유리아미노산의 분석 결과는 하기 표 3에 나타냈다. 표 3에서, 각 성분의 단위는 g/100g이다.The amino acid content of the wheat worm was analyzed using an automatic analyzer. Specifically, 20 ml of anhydrous alcohol was added to 2 g of the wheat-worm sample for each of Comparative Examples and Examples, homogenized, and centrifuged at 3000 rpm for 30 minutes using a centrifugal separator to separate the supernatant (A) (B), which was obtained by homogenization and centrifugation again in the same manner as above, was mixed with the supernatant A, and the supernatant A was mixed with the supernatant A (WB-2001, Heidolph , Kelheim, Germany) to remove the alcohol in the supernatant. 8 ml of HPLC water was added to the concentrated solution, and 0.2 g of sulfosalicylic acid reagent was dissolved. The mixture was allowed to stand at 4 ° C for 1 hour, centrifuged again at 3000 rpm for 30 minutes, and the supernatant was collected, adjusted to 10 ml with water for HPLC, and filtered through a 0.2 μm membrane filter (Whatman, Maidstone, UK) Followed by filtration to prepare a sample solution for analysis. The free amino acid analyzer (S430, SYKAM, Eresing, Germany) was used for the analysis of free amino acids. The buffer used was analyzed for two hours per sample using lithium buffer solution and ninhydrin reagent. . The analysis results of the free amino acids are shown in Table 3 below. In Table 3, the unit of each component is g / 100g.
표 3을 보면, 본 발명의 사료 조성물을 급여한 밀웜 체내에서 다양한 필수 아미노산의 함량 또한 증가된 것을 확인할 수 있다. 밀웜의 주요 아미노산 구성을 보면, 식품의 감칠맛의 성분인 Glutamic acid가 가장 많은 함량을 가지고 있으며, 그 다음으로 Aspartic acid, Proline, Alanine, Valine, Leucine, Tyrosine이 주로 구성을 이루고 있었다. Aspartic acid는 MSG에서 생성이 가능하다는 보고가 있는 바, MSG를 포함하는 본 발명의 사료의 급여 영향으로 인하여 대조군인 비교예에 비해 실시예들에서 높은 함량을 보이는 것으로 판단된다. Table 3 shows that the content of various essential amino acids was increased in the worm body fed with the feed composition of the present invention. Glutamic acid was the most abundant amino acid in food, followed by Aspartic acid, Proline, Alanine, Valine, Leucine and Tyrosine. Aspartic acid has been reported to be able to be produced in MSG, and it is considered that the content of Aspartic acid is higher in the Examples than the Comparative Example which is the control group due to the feeding effect of the feed of the present invention including MSG.
밀웜의 지방산 성분 분석을 위해서는, 먼저 밀웜 시료 2g을 chloroform-methanol로 추출·여과하여 감압농축한 지방질 약 100㎎을 가지형 플라스크에 취하고 1N-KOH ethanol 용액 3 ㎖를 섞어 유지방울이 없어질 때까지 교반시킨 다음 14%(v/v) BF3-Methanol 3 ㎖를 가했다. 환류냉각기를 부착하여 5분간 80℃에서 가열하여 methylester화 하였고, 이 용액에 NaCl 포화용액 3㎖를 가하고, 다시 hexane 1㎖를 가하여 흔들어 섞은 후 시험관에 옮겨 정치하였고 상층을 분취하여 무수 Na2SO4를 넣어 수분을 제거하고 0.5㎖를 vial에 채취한 후 GC(Shimadzu GC-17A, Shimadzu co., Japan)로 분석하였다. 지방산의 분석 결과는 하기 표 4에 나타냈다. 표 4에서, 각 성분의 단위는 g/100g TFA(total fatty acids)이다.In order to analyze the fatty acid composition of the wheat worm, 2 g of the wheat worm sample is extracted with chloroform-methanol, filtered, and 100 mg of the fat concentrated under reduced pressure is taken in an eggplant-shaped flask and mixed with 3 ml of 1N-KOH ethanol solution And then 3 ml of 14% (v / v) BF3-Methanol was added thereto. The mixture was heated to 80 ° C for 5 minutes with a reflux condenser and methylesterized. To this solution was added 3 ml of a saturated solution of NaCl, and 1 ml of hexane was added. The mixture was shaken and transferred to a test tube. The upper layer was separated and washed with anhydrous Na 2 SO 4 , And 0.5 ml was collected in a vial and analyzed by GC (Shimadzu GC-17A, Shimadzu co., Japan). The analysis results of the fatty acids are shown in Table 4 below. In Table 4, the unit of each component is g / 100 g of TFA (total fatty acids).
밀웜의 불포화지방산 중에선 Oleic acid 및 Linolelaidic acid의 함량이 높은 것으로 나타났다. Oleic acid는 기억력 증진, 치매 예방과 같이 인체의 건강을 향상시키는 효과를 가진 것이 알려져 있는 바, 밀웜의 유지 성분이 고기능성 불포화지방산을 높은 함량으로 포함하고 있어 식품 소재로 적용되기에 영양학적으로 우수한 것을 확인할 수 있다.The content of oleic acid and linolelaidic acid was higher in the unsaturated fatty acid of mullum. Oleic acid is known to have the effect of improving the health of the human body such as memory enhancement and prevention of dementia. Since the maintenance ingredient of the wheat worm contains a high content of high-functional unsaturated fatty acid, .
<MSG 급여된 밀웜을 이용한 기능성 식품소재 표준화 제조공정><Standardized manufacturing process of functional food materials using MSG-fed wheatgrass>
식품소재로서 표준화를 위한 제조 과정은 원료평량단계, 원료세척단계, 동결건조단계 및 원료화 단계의 과정으로 구분하여 진행했다.The manufacturing process for standardization as food material was divided into the steps of raw material weighing step, raw material washing step, freeze drying step and raw materializing step.
사료는 밀기울과 MSG를 9:1 중량비로 혼합하여 제조하였다. 제조된 사료로 사육한 밀웜 100kg을 원재료로 3 Lot으로 사용하였다. 30℃의 온수로 10분간 세척을 수행한 후, -70℃, 5 mTorr에서 동결건조하였다. 수분함량 5% 이하의 식품소재용 곤충분말로 제조하였으며, 수율은 42㎏이고 GABA 함량은 평균 13.96㎎/g였다.The feeds were prepared by mixing wheat bran and MSG in a weight ratio of 9: 1. 100kg of wheat worms fed with the prepared feeds were used as 3 raw materials. After washing for 10 minutes with warm water at 30 ° C, it was lyophilized at -70 ° C and 5 mTorr. The yield of the insect powder was 42 ㎏ and the average content of GABA was 13.96 ㎎ / g.
(GABA, 단위 mg/g) Experiment result
(GABA, unit mg / g)
(mg/g)Average
(mg / g)
<MSG 급여된 밀웜을 이용한 기능성 식품소재 물성검사><Functional food material property test using MSG-fed wheat worm>
당도와 pH는 상기 제조된 곤충분말과 증류수를 1:10로 비율로 혼합 후 균질기(IKA T 25 digital ULTRA-TURRAX, IKA Ltd., Staufen, Germany)를 사용하여 균질화한 후 당도계(Atago Pocket Refractometer Pal-1, Atago Co., Ltd., Tokyo, Japan)와 pH meter (SevenEasy 520, Mettler-Toledo Ltd., Schwerzenbach, Switzerland)로 측정하였다. 곤충분말의 색도측정은 색차계(CR-300, Minolta Co, Osaka, Japan)을 사용하여 명도(L,lightness), 적색도(a, redness), 황색도(b, yellowness)값으로 표시하였다. 각 시료당 3회 반복 측정하여 그 평균값을 하기 표 6에 나타내었다.The sugar content and pH were measured by homogenizing the insect powder and distilled water at a ratio of 1:10, homogenizing the mixture using a homogenizer (IKA T 25 digital ULTRA-TURRAX, IKA Ltd., Staufen, Germany) Were measured with a pH meter (SevenEasy 520, Mettler-Toledo Ltd., Schwerzenbach, Switzerland) and a pH meter (Pal-1, Atago Co., Ltd., Tokyo, Japan). Lightness, redness, and yellowness of the insect powder were measured using a colorimeter (CR-300, Minolta Co, Osaka, Japan). The average value of the measurement was repeated three times for each sample and the results are shown in Table 6 below.
(Brix)Sugar content
(Brix)
상기 제조된 곤충분말의 조직감은 P/50R cylinder probe를 이용하여 Texture analyzer (TX-XT2, Stable Micro System, Haslemere, Surrey, UK)로 측정하였다. 지름과 높이가 3.5cm인 원통에 시료 4g을 넣은 후, pre-test speed와 test speed, posttest speed는 2.0 mm/s, distance는 10.0 mm, trigger force는 5.0 g, compression mode로 측정하고 그 결과를 하기 표 7에 나타냈다.The texture of the insect powder was measured with a texture analyzer (TX-XT2, Stable Micro System, Haslemere, Surrey, UK) using a P / 50R cylinder probe. After loading 4 g of sample into a cylinder of diameter and height of 3.5 cm, the pre-test speed, test speed, posttest speed was 2.0 mm / s, distance was 10.0 mm, trigger force was 5.0 g and compression mode. Shown in Table 7 below.
상기 제조된 곤충분말의 영양성분은 식품공전에 기재된 방법에 따라, 탄수화물, 단백질, 지방, 포화지방, 트랜스 지방, 콜레스테롤, 나트륨 함량 분석하고 그 결과를 하기 표 8에 나타냈다.Protein, fat, saturated fat, trans fat, cholesterol, and sodium content of the insect powder were analyzed according to the method described in the Food and Drug Administration, and the results are shown in Table 8 below.
항산화 활성은 라디칼 소거 활성을 측정하여 확인하였다. DPPH(1,1-diphenyl-2-picrylhydrazyl) 라디칼 소거 활성은 함량은 시료를 2g을 80% 메탄올 20㎖과 혼합 후 균질기를 이용하여 3분간 균질화 하였다. 원심분리를 이용하여 상등액을 분리 후 여과지를 이용하여 여과한 메탄올 추출물을 시료로 사용하였다. 시료 150㎕에 DPPH 용액을 가하여 암실에서 30분 동안 반응시켜 517nm에서 흡광도를 측정하였다. 측정결과, 밀웜은 DPPH radical(Trolox (uM)) 7.57로 나타나 우수한 항산화 활성을 나타냈다.Antioxidant activity was determined by measuring the radical scavenging activity. DPPH (1,1-diphenyl-2-picrylhydrazyl) radical scavenging activity was obtained by mixing 2 g of sample with 20 ml of 80% methanol and homogenizing for 3 minutes using homogenizer. The supernatant was separated by centrifugation, and the methanol extract was filtered using a filter paper. The DPPH solution was added to 150 μl of the sample, reacted in the dark room for 30 minutes, and absorbance was measured at 517 nm. As a result, the antimicrobial activity of the wheat worm was shown to be DPPH radical (Trolox (uM)) 7.57.
상기 검사결과를 보면, 본 발명에 따른 사료를 급이하여 사육된 밀웜의 유충은 식품에 적용하기 적합한 특성을 가지며, GABA의 섭취를 위하여 이용될 수 있는 것을 확인할 수 있다. 또한, 곤충의 중요 영양성분인 단백질 함량이 매우 높아 단백질 섭취가 필요한 대상에 소량의 섭취로 많은 요구량을 흡수가 가능할 것으로 보인다.As a result of the test, it can be confirmed that the larva of the wheat worms fed with the feed according to the present invention has characteristics suitable for food and can be used for the ingestion of GABA. In addition, protein content, which is an important nutrient of insects, is so high that it can be absorbed in a small amount to a large amount of protein intake.
<MSG 급여된 밀웜의 체내 가바 및 생리활성물질 생성 확인><Confirmation of production of gabas and physiologically active substances in the body of MSM-fed wheat worms>
MSG농도 및 건조방법에 따른 밀웜 내 GABA 생성 함량을 확인하기 위한 실험을 수행하였다. 다양한 MSG농도를 함유한 배지를 이용하여 90일간 배양한 밀웜 유충을 사용하였으며, 건조방법 및 추출용매를 달리하여 밀웜의 추출물 시료를 준비하였다.Experiments were conducted to determine the amount of GABA production in wheat worms according to MSG concentration and drying method. The larvae were cultured for 90 days in a medium containing various concentrations of MSG. Extract samples of wheat worms were prepared by different drying methods and extraction solvents.
[%(w/v)]MSG concentration in feed
[% (w / v)]
water
각 시료를 분쇄 후 밀웜 시료를 추출용매를 이용하여 1.5 g/10㎖의 비율로 30℃에서 24시간 추출하였다. 추출 후 각 제조예별 시료를 1㎖씩 채취하여 원심분리(13,000 rpm, 3분)를 통해 불순물을 제거한 추출물로 준비하여 생리활성물질을 분리정제하였다. Each sample was pulverized and extracted with a extraction solvent at a rate of 1.5 g / 10 ml at 30 ° C for 24 hours. After extraction, 1 ml of each sample was taken and centrifuged (13,000 rpm, 3 minutes) to remove impurities. The physiologically active substance was purified and purified.
GABA정성분석은 Thin-layer chromatograpy(TLC)를 이용하여 수행하였다. Holdiness M.R (1983) Chromatographic analysis of glutamic acid decarboxylase in biological samples. J. Chromatogr. 277, 1-24. 문헌을 참고하였다. 각 제조예별 시료를 실리카 겔 TLC판에 0.5㎕를 점적한 뒤, n-butanol - acetic acid - water (5:3:2, v/v/v)의 전개용매를 이용하여 2차 전개하였다. 2차 전개 후, 0.2% (w/v) ninhydrin (in ethanol) 발색 시약을 이용하여 110℃에서 10분간 가열·건조하였다. 수행결과는 도 2 및 3에 도시하였다. 도 2 및 도 3에서, 대조군으로 GABA 1%(w/v)를 사용하였다.GABA qualitative analysis was performed using Thin-layer Chromatography (TLC). Holdiness M. R (1983) Chromatographic analysis of glutamic acid decarboxylase in biological samples. J. Chromatogr. 277, 1-24. Reference is made to the literature. 0.5 μl of each sample was loaded onto a silica gel TLC plate and then developed using a developing solvent of n-butanol-acetic acid-water (5: 3: 2, v / v / v). After the second development, it was heated and dried at 110 ° C for 10 minutes using 0.2% (w / v) ninhydrin (in ethanol) color developing reagent. The results are shown in Figures 2 and 3. 2 and 3, 1% (w / v) of GABA was used as a control.
도 2 및 3을 참고하면, 에탄올을 추출용매로 이용한 추출물에서는 GABA를 확인할 수 없고, 물을 이용하여 추출하는 경우 GABA가 추출되는 것을 확인할 수 있었다. 사료 내 MSG 농도가 10 ~ 15%(w/v)로 처리된 경우 GABA 함량이 현저하게 증가되는 것으로 나타났다.2 and 3, GABA was not confirmed in the extract using ethanol as an extraction solvent, and GABA was extracted when it was extracted with water. GABA content was significantly increased when the feed MSG concentration was 10 ~ 15% (w / v).
GABA 정량분석은 PITC(phenylisothiocyanate) 유도체화를 통한 정량분석으로 수행하였다. Rossetti V and Lombard A (1996) Determination of glutamate decarboxylase by high-performance liquid chromatography. Journal of Chromatography B, 681 : 63-67 문헌에 기재된 내용을 변형하여 수행하였다. 각 시료를 10 ㎕씩 튜브에 넣은 후 진공농축기를 통해서 용매를 제거하고, 잔여물에 에탄올-물-triethylamine(TEA) (2:2:1, v/v/v) 용매를 20 ㎕를 넣어 용해시킨 뒤 진공농축기를 통해서 다시 용매를 제거하였다. 잔여물에 에탄올-물-TEA-PITC (7:1:1:1, v/v/v/v) 용매를 50 ㎕ 넣어준 뒤 20분간 상온에서 PITC 유도체화를 진행한 후 여분의 PITC 유도체화 시약을 진공농축기를 통해서 제거한 뒤 600 ㎕ solvent A로 용해시킨 뒤 HPLC 분석을 진행하였다. GABA농도별 HPLC 측정결과는 도 4에 도시하고, 밀웜 물 추출물별 HPLC 측정결과는 도 5에 도시하였다. GABA 정량분석결과는 표 10에 도시하였다.Quantitative analysis of GABA was performed by PITC (phenylisothiocyanate) derivatization. Rossetti V and Lombard A (1996) Determination of glutamate decarboxylase by high-performance liquid chromatography. Journal of Chromatography B, 681: 63-67. Add 10 μl of each sample to the tube, remove the solvent through a vacuum concentrator, add 20 μl of ethanol-water-triethylamine (TEA) (2: 2: 1, v / v / v) And the solvent was removed again through a vacuum concentrator. 50 μl of ethanol-water-TEA-PITC (7: 1: 1: 1, v / v / v / v) solvent was added to the residue and the PITC derivatization was carried out at room temperature for 20 minutes. The reagent was removed through a vacuum concentrator and dissolved in 600 μl of solvent A, followed by HPLC analysis. The results of HPLC measurement according to GABA concentration are shown in FIG. 4, and the results of HPLC measurement of each of the water extracts of wheat worm are shown in FIG. The results of GABA quantitative analysis are shown in Table 10.
(mg/mL)GABA concentration
(mg / mL)
(mL)Extract volume
(mL)
함량Total GABA
content
(mg/g)GABA content
(mg / g)
표 10을 보면, 동결건조 시료 분석결과에서 MSG 미첨가 시료, 5%, 10% 및 15% MSG 첨가 시료는 각각 0.009, 0.301, 2.238 및 2.423 mg/mL의 GABA를 함유함을 확인할 수 있었다.As shown in Table 10, the freeze-dried samples contained 0.009, 0.301, 2.238 and 2.423 mg / mL of GABA in the MSG-free sample, 5%, 10% and 15% MSG, respectively.
표 9 및 10을 통하여, 밀웜 사육시 급여되는 MSG가 GABA생성에 있어 중요한 인자로 작용하는 것을 확인하였으며, 이는 밀웜 장내에 생육하는 미생물의 존재에 따른 결과임을 간접적으로 증명한 것이다. MSG 농도를 달리 급여한 결과, MSG농도에 따라 선형적으로 GABA생성이 증가하지 않아, 고농도의 MSG를 사료에 첨가하더라도 고농도의 GABA를 생성하지 않는 것을 확인하였다. 미생물에 의한 유용물질 생성은 효소반응과 달리 미생물 생육과 환경에 대한 적응에 의한 대사산물이 생성되는 점과 각각 미생물마다의 고유한 특성에 의하여 MSG농도에 따른 선형적인 GABA생성이 이루어지지 않은 것으로 보이며, 따라서 경제성을 고려하면, 저농도의 MSG를 첨가하여 효과적으로 GABA를 생성하는 사육조건의 검토가 필요한 것을 확인하였다.Tables 9 and 10 show that MSG fed in the breeding of wheat worms plays an important role in the generation of GABA, which is an indirect result of the presence of microorganisms growing in the worms. As a result of feeding MSG concentration differently, GABA production did not increase linearly according to MSG concentration, and it was confirmed that high concentration of MSG did not produce high concentration of GABA even when added to feed. The production of useful substances by microorganisms seems to be different from that of enzymatic reactions and that the production of metabolites by adaptation to microorganisms and environment and the inherent characteristics of microorganisms do not seem to produce linear GABA according to MSG concentration . Therefore, considering the economical efficiency, it was confirmed that it is necessary to examine the breeding condition for effectively producing GABA by adding low concentration of MSG.
<MSG 급여된 밀웜의 체내 가바 성분의 효능 평가><EVALUATION OF EMERGENCY OF GABA INGREDIENTS IN THE MILS WRONGED WITH MSG>
GABA 수용체를 세포 발현 시킨 후 GABA 효능평가를 실시하였다. 수용체 발현을 위해 RNA transcription을 수행하였다. plasmid DNA linearization은 1.2~1.5㎍DNA, 10X buffer 3㎕, restriction enzyme 1㎕에 total 30㎕에 맞춰서 DW를 추가해서 넣고 37℃에서 2시간 incubation 시키고, 두 시간 후에 70㎕ 추가해 100㎕로 맞추고 같은 양 (100㎕)의 phenol (pH 8)을 넣어 voltex 후에, 12,000rpm으로 5분 동안 centrifuge 돌려주는 phenol extraction을 진행하였다. 상등액을 새로운 ET tube에 옮기고 부피의 0.1배 NaOAC와 부피의 2배 100% EtOH를 넣고 -20℃에 30분 정도 store한 후에, 13,000 ~ 14,000 rpm과 4℃에 20분 동안 centrifuge로 돌리고 상등액을 제거했다. 400㎕ 70%(v/v) EtOH를 넣고 다시 13,000rpm, 4℃에 5분 동안 centrifuge 돌려 다시 상등액을 제거하였다. 이 때 다시 한번 1분동안 centrifuge 돌려 EtOH를 최대한 제거하고 10분동안 건조시켰다. 다 건조된 후에 6㎕ DEPC로 pellet을 녹였다.After GABA receptor expression, GABA potency was evaluated. RNA transcription was performed for receptor expression. Plasmid DNA linearization was performed by adding DW to 1.2 μl of DNA, 1.2 μl of 10 × buffer, 1 μl of restriction enzyme and 1 μl of restriction enzyme, adding DW at 37 ° C for 2 hours, adding 70 μl after 2 hours to 100 μl, (100 μl) of phenol (pH 8) was added, and phenol extraction was carried out after centrifuging at 12,000 rpm for 5 minutes. The supernatant was transferred to a new ET tube and stored at -20 ° C for 30 minutes at a volume of 0.1 × NaOAC and twice the volume of 100% EtOH. The supernatant was then centrifuged for 20 minutes at 13,000 to 14,000 rpm and 4 ° C, did. 400 μl of 70% (v / v) EtOH was added, and the supernatant was again removed by centrifugation at 13,000 rpm for 5 minutes at 4 ° C. At this time, once again centrifuged for 1 minute, the EtOH was removed as much as possible and dried for 10 minutes. After drying, the pellet was dissolved with 6 μl DEPC.
in vitro transcription을 위해, pellet을 녹이고 2X NTP 10㎕, 10X buffer 2㎕, RNA polymerase 2㎕를 추가해 총 20㎕를 맞추고 37℃에서 2시간 incubation 시킨 후에 DNase 1㎕를 넣고 37℃에서 15분 동안 incubation 시켰다. Incubation이 끝나고 나서 DEPC 115㎕와 NaOAC 15㎕를 추가하고, 150㎕ phenol을 넣고 voltex 후 12,000rpm으로 5분 동안 centrifuge를 돌려 상등액을 새로운 ET tube에 옮겼다. For in vitro transcription, dissolve the pellet, add 2 μl of 2X NTP, 2 μl of 10 × buffer, and 2 μl of RNA polymerase, and incubate at 37 ° C for 2 hours. Add 1 μl of DNase and incubate at 37 ° C for 15 minutes . After incubation, 115 μl of DEPC and 15 μl of NaOAC were added, 150 μl of phenol was added, and the supernatant was transferred to a new ET tube by centrifugation at 12,000 rpm for 5 minutes.
옮긴 tube에 2배 부피의 isopropanol을 넣고 -20℃에 30min 정도 store한 후에, 13,000 ~ 14,000 rpm과 4℃에 25분동안 centrifuge로 돌리고 상등액을 제거하였다. 이 때 다시 한번 1분 동안 centrifuge 돌려 EtOH를 최대한 제거하고 10분 동안 건조시켰다. DEPC 11㎕로 pellet을 녹이고 전기영동으로 확인한 후에, 몇 개로 분주해서 -80℃ deep freezer에 보관하여, GABA 유전자 cRNA를 합성하였다.Two-fold volume of isopropanol was added to the transferred tube, stored at -20 ° C for 30 min, centrifuged at 13,000 ~ 14,000 rpm and 4 ° C for 25 min, and the supernatant was removed. At this time, once again centrifuged for 1 minute, the EtOH was removed as much as possible and dried for 10 minutes. After dissolving the pellet with 11 μl of DEPC and confirming it by electrophoresis, it was divided into several pieces and stored at -80 ° C deep freezer to synthesize GABA gene cRNA.
이후 합성 cRNA를 injection할 oocytes를 준비하였다. 충분한 동면 유도후 culture를 해서 Xenopus oocytes를 꺼내고, 꺼낸 oocytes는 pH7.5로 맞춘 OR2 buffer (5 mM HEPES at pH 7.6 and 18℃, 82.5 mM NaCl, 2.5 mM KCl, 1 mM MgCl2)에 두고 1㎖당 2㎎의 1 unit collagenase를 처리하고 shaker에 1시간 정도 shaking 하였다. 1시간 정도 후에 Xenopus oocytes를 먼저 OR2 buffer로, 후에 pH7 .5로 맞춘 ND96 buffer (5 mM HEPES, 96 mM NaCl, 2 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2)로 wash 하고, animal pole과 vegetable pole의 경계선이 뚜렷하며 animal pole이 전체적으로 검정색인 건강한 oocytes를 골랐다. Then, oocytes were injected to inject synthetic cRNA. Xenopus oocytes were removed from the culture after sufficient hibernation, and oocytes removed were placed in OR2 buffer (5 mM HEPES at pH 7.6 and 18 ° C, 82.5 mM NaCl, 2.5 mM KCl, 1 mM MgCl 2 ) Treated with 1 unit of collagenase (2 mg) and shaked on shaker for 1 hour. After 1 hour, Xenopus oocytes were first washed with OR2 buffer and then with ND96 buffer (5 mM HEPES, 96 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 1.8 mM CaCl 2 ) healthy oocytes with a clear border between vegetable poles and an animal pole as a whole were selected.
유리관을 Narishige's PC-10 micropipette puller를 이용해 injection용 바늘을 만든다. PC-10 micropipette puller는 온도를 다르게 하여 바늘의 뾰족함 정도를 조절할 수 있는데, 실험실에 구비된 oocyte pipette에 맞도록 1step은 89.9℃, 2step은 50.3℃로 가열하여 바늘을 만들었다. 만든 바늘은 Narishige MF-900 microforge를 이용해 구멍을 4μm 크기로 비스듬하거나 반듯하게 만들었다. 멍을 뚫은 바늘을 mineral oil로 채우고 oocyte pipette에 꽂아, cRNA를 Xenopus oocytes에 40ng씩 주입하였다. Injection을 마친 후 ND96 buffer에 담아 18℃ shaker에 보관하였다. Oocytes에 주입 된 RNA는1~2일 후에 발현하는데, oocytes의 상태를 유지하기 위해 하루에 두 번, 아침과 저녁때마다 buffer를 갈아주었다.Use a Narishige's PC-10 micropipette puller to make injection needles for the injection tube. PC-10 micropipette puller can adjust the sharpness of the needle by changing the temperature. Needles were made by heating to 89.9 ℃ for 1step and 50.3 ℃ for 2 steps to fit the oocyte pipette equipped in the laboratory. The needle was slanted or flattened to 4μm using Narishige MF-900 microforge. The bruised needle was filled with mineral oil, inserted into an oocyte pipette, and cRNA was injected into Xenopus oocytes at 40ng. After injection, the cells were placed in ND96 buffer and stored in a shaker at 18 ° C. The RNA injected into the oocytes was expressed 1-2 days later, and the buffer was changed twice a day, morning and evening to maintain the state of oocytes.
전기생리실험은 two microclectrode voltage clamp 방법으로 수행하였다. 하나의 oocyte 를 plexiglass recording chamber에 놓고 1.8 mM Ca2 + frog Ringer’s solution ND96 (조성성분 mM: 115 NaCl, 2 KCl, 1.3 Na2HPO4, 1.8 CaCl2; pH 7.4)을 분당 3-7 ㎖의 유속으로 관류하였다. 두 유리전극의 저항의 크기는 3 M KCl 용액을 채워 1-3 MΩ 이내로 하였다. Oocyte Clamp (OC 725C, Warner Instruments, Hamden, CT, USA)를 이용하여 -50 mV의 고정막전압하에서 실험을 하였으며 0.2 μA 이상의 기저전류가 있는 oocyte는 실험에 사용하지 않았다. GABA receptor를 통해 GABA에 의해 유도되는 최대전류를 측정하기 위해서 이전 연구에서의 100uM GABA을 사용하였고, ND96 용액을 2분간 미리 관류한 전류를 측정하였다. GABA는 약 10~30초 동안 최대전류가 나타날 때까지 투여하였다. 각 실험전류의 전, 후에 기준치가 회복되는 것을 확인하였으며, 이전 약물의 투여로 인한 잔류효과를 배제하기 위하여 기준치가 90% 이상 회복되는 것을 확인하였다. 실험간 5~30분의 회복기가 소요되었다. GABA는 Clampex v 5.7 (Axon Instruments, Burlingame, CA, USA) 프로그램을 이용하여 computer 통제하에 miniature solenoid valve (LFAA series, Westbrook, CT, USA)를 통하여 투여하였다. 이 valve의 용액 교환시간은 0.5초였다.The electrophysiological experiments were performed by two microcrocrode voltage clamp method. Place one of the oocyte in plexiglass recording chamber 1.8 mM Ca 2 + frog Ringer's solution ND96 ( composition components mM: 115 NaCl, 2 KCl, 1.3
GABA 수용체 유전자를 세포내에 주입후 2일동안 배양 후 발현 여부를 확인하기 위해서 시그마에서 구입한 순도 99% 이상의 GABA 단일 물질을 처리하여 GABA 수용체의 세포 발현을 확인하였다. 이는 도 6에 도시하였다.In order to confirm the expression of the GABA receptor gene after culturing for 2 days after the injection of the GABA receptor gene into the cells, the GABA receptor monoclonal antibody, which was purchased from Sigma and having a purity of 99% or more, was treated to confirm the cell expression of the GABA receptor. This is shown in Fig.
순수 GABA 단일 성분을 100 uM을 처리하여 발현 여부를 확인하였으나, 밀웜에서 물질을 추출하여 사용될 실험군의 처리 확인을 위해서 w/w 단위로 실험을 진행하였다. 따라서 GABA의 분자량이 101.12 이므로 100 uM의 순수 GABA 단일 물질의 질량은 10.312 ug/ml 이다. 따라서 전기 생리 실험에 사용되어지는 ND96 buffer에 약 10 ug/ml의 용량의 밀웜 추출물을 분리후 처리하였다. 밀웜 추출물은 10 g을 분쇄하여서 10 ml의 물을 처리하여서 O/N incubation후에 원심 분리하여서 상층액을 분리하여서 ND96 buffer에 섞어서 사용하였다. 발현 여부를 확인후에서 농도 구배 의존성 실험을 실시하고 그 결과를 도 7에 도시하였다. GABA발현 세포에 순수 단일 물질 GABA에 의해 발현된 세포 활성을 확인하였고, 농도 의존적으로 활성을 나타내는 것을 확인하였고, 또한 가역적인 작용으로 활성 조절을 하는 것을 확인하게 되었다.100 μM of the pure GABA single component was treated to confirm the expression. However, in order to confirm the treatment of the experimental group, the experiment was conducted in w / w unit. Therefore, since the molecular weight of GABA is 101.12, the mass of 100 uM of pure GABA single substance is 10.312 ug / ml. Therefore, the wormworm extract of about 10 ug / ml was isolated and treated in ND96 buffer used for electrophysiological experiments. Ten milligrams of Millworm extract was prepared by pulverizing 10 ml of water, centrifuging after O / N incubation, separating supernatant and mixing with ND96 buffer. After confirming the expression level, a concentration gradient dependence test was conducted and the results are shown in Fig. GABA-expressing cells were confirmed to have cell activity expressed by pure single substance GABA, and it was confirmed that they exhibited activity in a concentration-dependent manner, and their activity was regulated by reversible action.
이에, MSG 급여하여 사육한 밀웜의 물 추출물을 이용하여 활성 조절을 확인하였다. 밀웜 추출물의 용매를 이용해서 녹인후에 원심 분리하여 찌거기를 제거후 상층액을 분리하여 전기생리 실험 용액인 ND96 buffer에 희석하여 사용하였다. 최초 GABA 단일성분을 GABA수용체 발현 세포에 처리하여 수용체의 활성을 확인한 후에 밀월 추출물의 농도를 증가시켜서 작용을 확인하고 그 결과를 도 8에 나타냈다.Thus, the control of the activity was confirmed by using the water extract of the wheat worms fed with MSG. After dissolving in the solvent of extracts of Millworm, the supernatant was separated by centrifugation, and diluted in ND96 buffer for electrophysiological experiments. The first GABA single component was treated with GABA receptor expressing cells to confirm the receptor activity and then the concentration of the honey extract was increased to confirm the action. The results are shown in FIG.
도 8을 참고하면, 밀웜 추출물이 GABA 수용체를 활성시키고, 이 작용은 농도 의존적으로 작용하며, 가역적으로 작용하는 것을 확인할 수 있었다. 농도 의존적인 성질을 확인하기 위해서 농도에 의거한 효과를 분석하고 일반화하여, 이를 농도의존성 효능의 검증을 나타내는 Hill equation 분석을 통해서 농도의존성을 확인하고 그 결과를 도 9 및 표 11에 나타냈다. equation식과 분석 값은 표 12에 나타냈다.Referring to FIG. 8, it was confirmed that the wheat worm extract activates the GABA receptor, and this action acts in a concentration-dependent manner and acts reversibly. In order to confirm the concentration-dependent properties, the concentration-based effects were analyzed and generalized, and the concentration dependence was confirmed by Hill equation analysis showing the effect of the concentration-dependent effect. The results are shown in FIG. 9 and Table 11. The equation and the analytical values are shown in Table 12.
(ug/ml)Wheat worm extract concentration
(ug / ml)
도 9 및 표 11을 참고하면, 커브를 통해 부드러운 농도의존 효능을 확인할 수 있었다.Referring to FIG. 9 and Table 11, smooth concentration-dependent efficacy can be confirmed through a curve.
추가로, 전압의존성 연구를 실시하였다. 이는 밀웜 추출물이 GABA수용체의 활성을 생리학적으로 안전하게 조절하여 작용하는지 확인하기 위하여 수행하는 것으로, GABA의 작용이 생리학적, 자연적이며 특이적인 작용인지를 확인하기 위한 것이다. 밀웜 추출물이 GABA 수용체의 활성에 물리적인 비규칙적으로 작용한다면, 예를 들어서 전압의존적으로 작용하지 않고 비의존적으로 작용한다면 이는 GABA 수용체에 생물학적 작용이 아닌 물리적인 파괴 및 비특이적인 작용이 될수 있다. In addition, a voltage dependency study was performed. The purpose of this study is to determine whether the action of GABA is a physiological, natural, and specific action, in order to confirm whether the Wormworm extract can physically and safely control the activity of the GABA receptor. If the wheat-worm extract acts physically and irregularly on the activity of the GABA receptor, for example, it does not act in a voltage-dependent manner but acts independently, which may result in physical destruction and non-specific action on the GABA receptor rather than biological action.
대조군으로 GABA를 처리하기 전과 GABA 단일 물질을 처리하여 reverse potential voltage를 확인한 후, 밀웜 추출물을 처리하였을 때 이 reverse potential voltage가 변화하거나 이동하게 되면 이는 생리학적인 효능이 아니라 물리적인 비특이적 작용을 나타내는 것으로 판단하게 된다. 예를 들어, 세포막에 특정 물질이 투입되거나 막단백질에 비특이적 작용하는 작용 뿐 아니라 세포막 외부에 존재하는 탄수화물들과 작용하여 세포 활성을 나타낸다면 이 reverse potential voltage가 변화될 것이다. As a control, the reverse potential voltage was checked before treatment with GABA alone and the GABA single substance was treated. After the reverse potential voltage was changed or shifted when treated with the wormwood extract, it was not a physiological effect but a physical nonspecific action . For example, the reverse potential voltage will change if it acts on carbohydrates outside the cell membrane as well as the action of specific substances on the cell membrane or nonspecific action on the membrane protein.
도 10을 참고하면, 밀웜 추출물을 처리하였을 때 reverse potential voltage의 변화가 유지되면서 수용체의 작용을 나타내는 것을 확인할 수 있다. 이는 본 발명의 밀웜 추출물에 포함되는 GABA의 생물학적인 정확한 작용을 보여주는 것이다.Referring to FIG. 10, it can be seen that the treatment of the extract of the wheat worm exhibits the action of the receptor while maintaining the change of the reverse potential voltage. This shows the biological correct action of GABA contained in the wormworm extract of the present invention.
본 발명에 따른 글루탐산을 포함하는 사료 조성물을 급이하여 사육한 밀웜 체내의 증진된 GABA는 기존 GABA와 동일하게 GABA 수용체에 생물학적으로 정확하게 작용하는 것을 확인할 수 있다. 이를 통하여, 본 발명의 글루탐산 사료 조성물을 급이하여 사육한 밀웜이 GABA 보충 및 섭취를 위한 식품소재로 적용하기 안전한 소재인 것을 확인할 수 있다.It can be confirmed that the enhanced GABA in the worm body fed with the feed composition containing glutamic acid according to the present invention acts biologically accurately on the GABA receptor as in the conventional GABA. As a result, it can be confirmed that the wheat worms fed with the glutamate feed composition of the present invention are safe as a food material for GABA supplementation and ingestion.
Claims (7)
A composition for enhancing growth and gamma aminobutyric acid (GABA) incorporating monosodium glutamate as an active ingredient.
상기 모노소듐 글루타메이트는 상기 사료 조성물 100중량%를 기준으로 5 내지 50중량%의 함량으로 포함되는 것을 특징으로 하는 밀웜 사료 조성물.
The method according to claim 1,
Wherein the monosodium glutamate is contained in an amount of 5 to 50% by weight based on 100% by weight of the feed composition.
A method for breeding wheat worms, comprising feeding the feed composition of claim 1 or 3 to a wheat worm.
The wheat worm according to claim 4, wherein the wheat worm is raised by the breeding method to increase the content of GABA.
A food composition comprising the wheat worm of claim 5.
A feed additive comprising the wheat worm of claim 5.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170111870A KR101836918B1 (en) | 2017-09-01 | 2017-09-01 | Feed Composition for Mealworm, Breeding Method for Mealworm Using the Same, And Food Composition Obtained Therefrom |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170111870A KR101836918B1 (en) | 2017-09-01 | 2017-09-01 | Feed Composition for Mealworm, Breeding Method for Mealworm Using the Same, And Food Composition Obtained Therefrom |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101836918B1 true KR101836918B1 (en) | 2018-03-09 |
Family
ID=61728062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170111870A KR101836918B1 (en) | 2017-09-01 | 2017-09-01 | Feed Composition for Mealworm, Breeding Method for Mealworm Using the Same, And Food Composition Obtained Therefrom |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101836918B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200022071A (en) | 2018-08-22 | 2020-03-03 | 영농조합법인 엔자임팜 | Shake using Edible Insect and Manufacturing Method for the Same |
KR20200071030A (en) * | 2018-12-10 | 2020-06-18 | 전남대학교산학협력단 | Strain having improved productivity of GABA, a composition for producing GABA containing the same, a method for producing GABA using the same, and a method for increasing the amount of GABA in insects using the same |
KR20210040020A (en) * | 2019-03-18 | 2021-04-12 | 주식회사 케이오씨바이오텍 | Composition for improving meat quality comprising extract of Schisandra chinensis stem as an active ingredient and method for producing the same |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101187512B1 (en) * | 2012-03-29 | 2012-10-02 | (주)셀텍 | METHOD FOR PREPARING FEED ADDITIVE CONTAINING γ-AMINOBUTYRIC ACID |
-
2017
- 2017-09-01 KR KR1020170111870A patent/KR101836918B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101187512B1 (en) * | 2012-03-29 | 2012-10-02 | (주)셀텍 | METHOD FOR PREPARING FEED ADDITIVE CONTAINING γ-AMINOBUTYRIC ACID |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200022071A (en) | 2018-08-22 | 2020-03-03 | 영농조합법인 엔자임팜 | Shake using Edible Insect and Manufacturing Method for the Same |
KR20200071030A (en) * | 2018-12-10 | 2020-06-18 | 전남대학교산학협력단 | Strain having improved productivity of GABA, a composition for producing GABA containing the same, a method for producing GABA using the same, and a method for increasing the amount of GABA in insects using the same |
KR102274943B1 (en) | 2018-12-10 | 2021-07-08 | 전남대학교산학협력단 | Strain having improved productivity of GABA, a composition for producing GABA containing the same, a method for producing GABA using the same, and a method for increasing the amount of GABA in insects using the same |
KR20210040020A (en) * | 2019-03-18 | 2021-04-12 | 주식회사 케이오씨바이오텍 | Composition for improving meat quality comprising extract of Schisandra chinensis stem as an active ingredient and method for producing the same |
KR102322065B1 (en) | 2019-03-18 | 2021-11-04 | 주식회사 케이오씨바이오텍 | Composition for improving meat quality comprising extract of Schisandra chinensis stem as an active ingredient and method for producing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Russo et al. | Evaluation of protein concentration, amino acid profile and antinutritional compounds in hempseed meal from dioecious and monoecious varieties | |
ITO | Nutritional requirements of the silkworm, Bombyx mori L. | |
BRPI0710665A2 (en) | feed formulations containing docosahexaenoic acid | |
KR101971984B1 (en) | Mixed probiotics using heat-treated whole fat soybean, method for preparing the same, and method for producing high quality Korean native steers meat by using the mixed probiotics | |
KR101836918B1 (en) | Feed Composition for Mealworm, Breeding Method for Mealworm Using the Same, And Food Composition Obtained Therefrom | |
CN101357223A (en) | Preparation method of anti-stress agent for fishing | |
KR101997365B1 (en) | Feed composition for tenebrio molitor using agricultural byproducts and breeding method of tenebrio molitor using it | |
CN108029885A (en) | Pet care product and preparation method thereof | |
Ukoroije et al. | Cockroach (Periplaneta americana): Nutritional value as food and feed for man and livestock | |
CN108260731A (en) | A kind of nutritive cream for controlling pet dog cat weight | |
McCay | The nutritional requirements of Blattela germanica | |
Koutsos et al. | The role of insects for poultry feed: present and future perspective | |
RU2366271C1 (en) | Forage additive as preventive and treatment medium for domestic and farm animals | |
CN108077625B (en) | Pet dog phagostimulant and preparation method thereof | |
RU2038086C1 (en) | Method for extracting biologically active product from wax moth larvae | |
JP2003246743A (en) | Immunoregulatory composition | |
RU2725801C1 (en) | Method for increasing efficiency of young sturgeon fish growing | |
CN114451487A (en) | Eucommia ulmoides egg and production method thereof | |
Kovtunova et al. | Dynamics of amino acid profile of Musca domestica larva during cultivation on substrate enriched with microelements | |
JP5742060B2 (en) | Immunostimulant containing component derived from genus leek and method for producing immunostimulator | |
KR102042352B1 (en) | Composition for strengthening of muscle, preventing and treating Sarcopenia comprising Arachis hypogaea skin | |
RU2626626C1 (en) | Method for preparing combined fodder for trepang juveniles | |
Varlyakov et al. | Changes in Blood Biochemical Indices in Yearling Rams after Dietary Supplementation of Optigen. | |
RU2764195C1 (en) | Adaptogenic phytosynbiotic feed additive for calves | |
KR101613440B1 (en) | Manufacturing methods of probiotics comprising garlic husk |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |